FDA expands use of Imbruvica to treat rare form of cancer
January 29, 2015 at 11:29 AM EST
Jan 29 (Reuters) - The U.S. Food and Drug Administration said it cleared an expanded use of Imbruvica to treat Waldenström's macroglobulinemia, a rare form of cancer that begins in the body's immune system.
